Bank Of New York Mellon Corp Roivant Sciences Ltd. Put Options Transaction History
Bank Of New York Mellon Corp
- $528 Trillion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ROIV
# of Institutions
318Shares Held
495MCall Options Held
1.29MPut Options Held
1.15M-
Sb Investment Advisers (Uk) LTD London, X071.4MShares$847 Million6.97% of portfolio
-
Viking Global Investors LP69.2MShares$821 Million2.91% of portfolio
-
Qvt Financial LP New York, NY66.7MShares$792 Million72.99% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$420 Million0.01% of portfolio
-
Morgan Stanley New York, NY29.3MShares$348 Million0.02% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.36B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...